The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

Share Price Information for ADVFN (AFN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.50
Bid: 10.00
Ask: 11.00
Change: 0.00 (0.00%)
Spread: 1.00 (10.00%)
Open: 10.50
High: 10.50
Low: 10.50
Prev. Close: 10.50
AFN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

29 Apr 2022 14:05

RNS Number : 9156J
ADVFN PLC
29 April 2022
 

29 April 2022

For immediate release

ADVFN PLC

("ADVFN" or the "Company")

Notice of General Meeting

 

The Board of ADVFN announces that at the General Meeting of the Company held today at 11.30am, all resolutions were passed on a poll. The total number of votes received on each resolution were as follows:

 

Resolution

For

% of votes cast

Against

% of votes cast

Votes cast as a % of issued share capital

Withheld

1

Anthony Wollenberg is appointed a director of the Company

15,043,663

71.73%

5,930,118

28.27%

79.70%

329

2

Amit Tauman is appointed a director of the Company

14,540,908

69.32%

6,432,873

30.67%

79.70%

329

3

Lord David Gold is appointed a director of the Company

14,540,908

69.32%

6,432,873

30.67%

79.70%

329

 

Notes:

1. Any proxy appointments which gave discretion to the Chairman have been included in the "against" total.

2. The Company's issued share capital (excluding treasury shares) at the date of the meeting was 26,315,319 ordinary shares of 0.2p each. Each ordinary share carries the right to one vote and, therefore, at the date of the meeting there were 26,315,319 voting rights in the Company.

3. A vote "withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "for" and "against" a resolution.

4. All percentages are shown to two decimal places.

 

Anthony Wollenberg, Amit Tauman and Lord David Gold have therefore been appointed as directors of the Company with immediate effect and the information required to be published in accordance with Schedule Two (g) of the AIM Rules for Companies is set out in the Appendix to this announcement.

 

Enquiries:

 

For further information please contact:

ADVFN PLC

Jonathan Mullins

+44 (0) 203 8794 460

 

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

 

Roland Cornish/Michael Cornish

+44 (0) 207 628 3396

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser to the Company in relation to the matters referred to in this announcement and its responsibilities as the Company's nominated adviser under the AIM Rules for Nominated Advisers are owed solely to London Stock Exchange plc and are not owed to the Company or to any Director or to any other person. Furthermore, Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this document or any matter referred to in it.

 

A copy of this announcement will be available on the Group's website:

 www.advfnplc.com

 

APPENDIX

INFORMATION ON THE NEW DIRECTORS

 

Mr Anthony Wollenberg

Anthony Wollenberg is an independent freelance solicitor (regulated by the SRA) specialising in securities, derivatives, gaming and the prosecution of fraud. During a long and distinguished legal career of over 45 years, Mr Wollenberg has held a number of senior roles at firms including Dentons, Salans and Rakisons (which he founded and which merged with Steptoe & Johnson). He has also acted as an arbitrator at the London Court of International Arbitration. In addition to his role as a solicitor, Mr Wollenberg has a significant corporate profile as a shareholder and director (and often founder and chairman) of a number of companies (one fully listed), predominantly within the betting/gaming industry. Of particular note, he is a founder shareholder and UK director of eToro, a major investment platform which is currently the subject of a US$8bn+ Nasdaq listing. eToro is regulated by the FCA and Mr Wollenberg is also regulated by the UK Gambling Commission.

 

Mr Amit Tauman

Amit Tauman (born in 1991) is an expert in artificial intelligence, reinforcement learning, algorithms and blockchain technology (applied to non-fungible tokens). He undertook a B.Sc. degree in mathematics and economics at Tel Aviv University, graduating in 2018 with distinction, following which he obtained an M.Sc. degree in mathematics and computer science (also with distinction) from the Weizmann Institute of Technology in Israel, with a particular emphasis on artificial intelligence. Mr Tauman was previously a research analyst focusing on biological computation and machine learning, and he is currently involved in building complex trading models using deep reinforcement learning and cutting-edge algorithms for automated stock trading.

 

Lord David Gold

Lord Gold is an English solicitor (admitted in 1975); a member of the House of Lords (since February 2011); Principal of David Gold & Associates (established in 2010) and Director of Gold Collins Associates (established in 2018); Chairman of the investment committee of Balance Legal Capital, a litigation funder (since its inception in 2015); and Chairman of ESCP Europe Business School (since 2018). He was also appointed as a corporate monitor by the US Department of Justice in respect of BAE Systems in 2010-2012, and has been a monitor for the UK Cabinet Office in respect of the Airbus Group since 2020.

 

As required under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies, further disclosures on the proposed directors are as follows.

 

1. Mr. Wollenberg

1.1 Anthony (Tony) Stephen Wollenberg, aged 72, has held the following directorships and/or partnerships in the past five years:

 

Current directorships and/or partnerships

Past directorships and/or partnerships

eToro (UK) Limited

Century Casino Bath Limited

 

Global Gaming Ventures (Bath) Limited

City & Eastern Limited

 

Global Gaming Ventures (Group) Limited

DDL167 Limited

 

Global Gaming Ventures (Southampton) Limited

Global Gaming Ventures Guarantors Limited

 

Livia's Health Foods Limited

Global Gaming Ventures (RP) Limited

 

Wondrous Holdings Limited

VGCH Limited

 

 

VGC Leeds Limited

 

 

VGC Developments Limited

 

 

1.2 Mr. Wollenberg holds no ordinary shares in the Company.

 

1.3 Mr. Wollenberg was formerly a director of VGCH Limited, previously known as Global Gaming Ventures (Holdings) Limited, between November 2015 and May 2019. A receiver to VGCH Limited was appointed on 17 August 2017 by ABC Funding, LLC. The receiver ceased to act on 19 August 2019 and VGCH Limited continues in existence. There was no loss to creditors.

 

1.4 Mr. Wollenberg was appointed a director of Livia's Health Foods Limited("LHF") in September 2020. On 17 February 2022 the directors of LHF appointed administrators. The administrators completed a pre-pack sale of LHF's business and assets for an initial consideration of £355,000 together with a deferred consideration based on revenue valued at £100,000. It is possible that all creditors will, in due course, be paid in full. The administration is ongoing.

 

1.5 There is no further information on Mr. Wollenberg required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

2. Mr. Tauman

2.1 Amit Endi Yosef Tauman, aged 30, has not held any directorships and/or partnerships in the past five years.

 

2.2 Mr. Tauman holds 2,045,230 ordinary shares in the Company, representing 7.83 per cent. of the issued share capital.

 

2.3 There is no further information on Mr. Tauman required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

3. Lord Gold

3.1 David Laurence Gold (Lord Gold), aged 71, has held the following directorships and/or partnerships in the past five years:

 

Current directorships and/or partnerships

Past directorships and/or partnerships

BLC1 FP LLP

C5 Holdings (UK) Limited

Broadclyst Limited

 

David Gold & Associates LLP

 

Derwent Films LLP

 

ESCP Europe Corporate Services Limited

 

ESCP Europe Business School

 

Gold Collins Associates Limited

 

Marylebone Capital Investments Limited

 

Medway Films LLP

 

Mole Films LLP

 

Southend & Westcliff Hebrew Congregation

 

T0day Group Limited

 

 

3.2 Lord Gold holds no ordinary shares in the Company.

 

There is no further information on Lord Gold required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMBDGDSGUDDGDC
Date   Source Headline
21st Mar 20249:49 amRNSHalf-year Report
9th Feb 202411:19 amRNSNew ADVFN Italia website is launched
12th Jan 20242:00 pmRNSResult of Meeting
28th Dec 20231:10 pmRNSResult of AGM
21st Dec 20237:00 amRNSFinal Results
5th Dec 20234:00 pmRNSNotice of AGM
16th Nov 20231:30 pmRNSHolding(s) in Company
21st Sep 202312:00 pmRNSADFVN connects audience to Doceo content
15th Aug 20236:05 pmRNSCorporate update
9th Jun 20236:15 pmRNSDirector/PDMR Shareholding
2nd Jun 202312:14 pmRNSTrading and corporate update
16th May 20234:33 pmRNSHolding(s) in Company
5th May 20233:06 pmRNSTotal Voting Rights
4th Apr 20237:00 amRNSIssue of Equity
30th Mar 20232:07 pmRNSHolding(s) in Company
30th Mar 20232:05 pmRNSHolding(s) in Company
23rd Mar 20235:02 pmRNSHolding(s) in Company
23rd Mar 20235:01 pmRNSHolding(s) in Company
23rd Mar 20235:00 pmRNSHolding(s) in Company
23rd Mar 20233:30 pmRNSDirector/PDMR Shareholding
20th Mar 20236:20 pmRNSAdmission update
14th Mar 202312:05 pmRNSFurther equity issue under the Open Offer
6th Mar 20237:00 amRNSHalf-year Report
6th Feb 202311:53 amRNSDirectorate Change
13th Jan 202311:19 amRNSResult of AGM
11th Jan 20231:15 pmRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202311:10 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.